Roger van den Heuvel
Principal, Corporate Strategy, Life Sciences Lead
Roger leads the Life Science sector within KPMG’s Corporate Strategy Group, which provides strategic advice through to execution support to current and future industry leaders across the globe. He has 20+ years of consulting experience and specializes in strategy formulation and (value-based) strategic transformations with a particular emphasis on disruptive technology/business models and ‘Future Proofing’. His areas of expertise include: Advisory, Deal Advisory, Deal strategy, Disruptive Technology, Healthcare, Life Sciences, Management Consulting, Pharmaceuticals, Strategy and Operations, Transformation.